1. Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
- Author
-
Vasileios‐Arsenios Lioutas, Nitin Goyal, Aristeidis H. Katsanos, Christos Krogias, Ramin Zand, Vijay K. Sharma, Panayiotis Varelas, Konark Malhotra, Maurizio Paciaroni, Aboubakar Sharaf, Jason Chang, Odysseas Kargiotis, Abhi Pandhi, Christoph Schroeder, Argyrios Tsantes, Efstathios Boviatsis, Chandan Mehta, Panayiotis D. Mitsias, Magdy H. Selim, Andrei V. Alexandrov, and Georgios Tsivgoulis
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Prior studies suggest an association between Vitamin K antagonists (VKA) and cerebral microbleeds (CMBs); less is known about nonvitamin K oral anticoagulants (NOACs). In this observational study we describe CMB profiles in a multicenter cohort of 89 anticoagulation‐related intracerebral hemorrhage (ICH) patients. CMB prevalence was 51% (52% in VKA‐ICH, 48% in NOAC‐ICH). NOAC‐ICH patients had lower median CMB count [2(IQR:1–3) vs. 7(4–11); P
- Published
- 2019
- Full Text
- View/download PDF